AstraZeneca Signs Deal With Canada to Provide 20 Million Coronavirus Vaccine Doses
AstraZeneca (NYSE: AZN) signed a large coronavirus vaccine-delivery deal with Canada on Friday. The big pharmaceutical company will deliver up to 20 million doses of its coronavirus vaccine candidate, AZD1222.
This isn't the first time AstraZeneca has signed a commitment to deliver enormous quantities of its coronavirus vaccine candidate before it's had a chance to prove itself safe and effective in a phase 3 clinical trial. In June, the company agreed to supply Europe with up to 400 million doses of AZD1222 with deliveries beginning by the end of the year. The company also has a deal with Brazil to provide around 30 million finished doses of the vaccine by December.
Image source: Getty Images.
Source Fool.com
